Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001; 104: 531-43.
Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106:473-81.
Fujita H, Yamagami T. Efficacy and safety of Chinese black tea (Pu-Ehr) extract in healthy and hypercholesterolemic subjects. Ann Nutr Metab 2008;53: 33-42.
Tsuchida T, Itakura H, Nakamura H. Reduction of body fat in humans by long-term ingestion of catechins. Prog Med 2002; 22: 2189-203.
Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992; 1127: 141-6.
Toris T, Satoh Y, Fujita H, Nagaoka T, Kawabata J. The structure and activity of Yunnan fermented tea on mixed bile salt micelles. Nippon Nougeikagakukaisi 2007; (suppl): 261.
Fujita H, Yamagami T. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 2008; 28: 450-6.
Uchiyama S, Taniguchi Y, Saka A, Yoshida A, Yajima H. Prevention of dietinduced obesity by dietary black tea polyphenols extract in vitro and in vivo. Nutrition 2011; 27: 287-92.
Kubota K, Sumi S, Tojo H, Sumi-Inoue Y, I-Chin H, Oi Y, et al. Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract. Nutr Res 2011; 31: 421-8.
Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis 2001; 21: 71-80.
Boyce CJ, Pickhardt PJ, Kim DH, Taylor AJ, Winter TC, Bruce RJ, et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 2010; 194: 623-8.
Speliotes EK, Massaro JM, Hoffmann U, Foster MC, Sahani DV, Hirschhorn JN, et al. Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 2008; 23: 894-9.
Azuma K, Kadowaki T, Cetinel C, Kadota A, El-Saed A, Kadowaki S, et al. Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States. Metabolism 2009; 58: 1200-7.
Machin D, Campbell MJ. Design of studies for medical research. Hoboken (NJ): John Wiley & Sons; 2005.
Ballarè M, Campanini M, Airoldi G, Zaccala G, Bertoncelli MC, Cornaglia G, et al. Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme A reductase inhibitors. Minerva Gastroenterol Dietol 1992; 38: 41-4.
Pierno S, De Luca A, Tricarico D, Roselli A, Natuzzi F, Ferrannini E, et al. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. J Pharmacol Exp Ther 1995; 275: 1490-6.
Tal A, Rajeshawari M, Isley W. Rhabdomyolysis associated with simvastatingemfibrozil therapy. South Med J 1997; 90: 546-7.
Fujita H, Yamagami T. Extract of black tea (pu-ehr) inhibits postprandial rise in serum cholesterol in mice, and with long term use reduces serum cholesterol and low density lipoprotein levels and renal fat weight in rats. Phytother Res 2008; 22: 1275-81.
Yoshino K, Hara Y, Sano M, Tomita I. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol Pharm Bull 1994; 17: 146-9.
Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010; 363: 245-56.